- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 04.11. | Glenmark Pharma's US subsidiary to launch 8.4% sodium bicarbonate injection in US market | 2 | capitalmarket.com | ||
| 03.11. | Glenmark Pharmaceuticals Ltd spurts 0.02%, rises for fifth straight session | 4 | capitalmarket.com | ||
| GLENMARK PHARMACEUTICALS Aktie jetzt für 0€ handeln | |||||
| 30.10. | Glenmark Pharmaceuticals Ltd up for third consecutive session | 3 | capitalmarket.com | ||
| 30.10. | Import von Glenmark: Engpass: Salbutamol aus Brasilien | 3 | APOTHEKE ADHOC | ||
| 23.10. | Glenmark Pharma set to launch Ropivacaine Hydrochloride Injection in US | 3 | capitalmarket.com | ||
| 28.09. | Glenmark, Granules, Zydus and others recall medicines in US over quality issues: USFDA | 2 | ZEE Business | ||
| 26.09. | Fierce Pharma Asia-Celltrion's Lilly plant buy; Rexulti's PTSD snub; Glenmark, Hengrui's ADC deal | 6 | FiercePharma | ||
| 25.09. | China's Hengrui Rises After Granting India's Glenmark Cancer Drug Rights in Up to USD1.1 Billion Deal | 2 | Yicai Global | ||
| 25.09. | Stock Alert: Glenmark Pharmaceuticals, Lupin, NTPC, Pipavav Port, Newgen | 2 | capitalmarket.com | ||
| 24.09. | In potential $1.1B deal, Glenmark grabs certain rights to Hengrui's ADC rival to Enhertu | 3 | FiercePharma | ||
| 15.09. | Dividendenbekanntmachungen (15.09.2025) | 13.542 | wallstreetONLINE (Dividenden) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) A&W FOOD SERVICES OF CANADA INC CA0002251027 0,48 CAD 0,2954 EUR ALLEGION PLC IE00BFRT3W74 0,51 USD 0,4345 EUR ALTRIA GROUP INC US02209S1033 1... ► Artikel lesen | |
| 08.09. | Glenmark Expands Phase 3 Study of Envafolimab to Multiple Regions | 2 | Mexico Business News | ||
| 05.09. | Glenmark Pharmaceuticals: Glenmark Initiates a Multi-Country Phase 3 Clinical Trial for Envafolimab in Resectable Stage III Non-Small Cell Lung Cancer | 317 | PR Newswire | DCGI grants No Objection Certificate to commence enrollment in India
Clinical Trial Applications underway in Russia, Brazil, and Mexico
MUMBAI, India, Sept. 5, 2025 /PRNewswire/... ► Artikel lesen | |
| 05.09. | Glenmark Pharmaceuticals: Glenmark Initiates a Multi-Country Phase 3 Clinical Trial for Envafolimab in Resectable Stage III Non-Small Cell Lung Cancer | 378 | PR Newswire | DCGI grants No Objection Certificate to commence enrollment in India
Clinical Trial Applications underway in Russia, Brazil, and Mexico
MUMBAI, India, Sept. 5, 2025 /PRNewswire/... ► Artikel lesen | |
| 02.09. | Glenmark Pharma's US arm to launch Eribulin Mesylate injection in the US market | 2 | capitalmarket.com | ||
| 20.08. | Alembic, Sun and Glenmark issue US drug recalls due to the presence of carcinogens or foreign matter | 5 | FiercePharma | ||
| 19.08. | Glenmark Pharma's US arm to launch Micafungin injection in the US market | 2 | capitalmarket.com | ||
| 18.08. | Glenmark Pharma shares tumble despite market-wide rally post-Q1 results | 2 | ZEE Business | ||
| 18.08. | Glenmark Pharma, HDFC Bank among 10 stocks that showed RSI Trending Up on August 14 | 3 | Times of India | ||
| 06.08. | Glenmark Pharmaceuticals Subsidiary Reaches $37.75 Million Settlement in US Antitrust Case | 3 | CPI |
1 2 3 4 Weiter >>
69 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SINOPHARM | 2,337 | +1,04 % | SINOPHARM (01099): LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION | ||
| CSPC PHARMA | 0,839 | -1,08 % | CSPC PHARMA (01093): VOLUNTARY ANNOUNCEMENT - MARKETING AUTHORISATION APPLICATION FOR PERTUZUMAB INJECTION ACCEPTED BY THE NMPA | ||
| WUXI BIOLOGICS | 3,651 | -1,03 % | WUXI BIO (02269): NEXT DAY DISCLOSURE RETURN | ||
| SHANGHAI FOSUN PHARMACEUTICAL | 2,550 | -0,39 % | FOSUN PHARMA (02196): NOTICE OF 2025 SECOND EXTRAORDINARY GENERAL MEETING | ||
| GEDEON RICHTER | 25,040 | -4,43 % | Gedeon Richter Plc.: Extraordinary Information | ||
| DR REDDYS | 11,800 | 0,00 % | DR REDDYS LABORATORIES LTD - 6-K, Report of foreign issuer | ||
| ASPEN PHARMACARE | 4,740 | 0,00 % | ASPEN PHARMACARE HOLDINGS LIMITED - Broad-Based Black Economic Empowerment Annual Compliance Report for the year ended 30 June 2025 | ||
| LUYE PHARMA | 0,350 | +3,55 % | LUYE PHARMA (02186): INTERIM REPORT 2025 | ||
| SHANGHAI PHARMACEUTICALS | 1,420 | +3,65 % | SH PHARMA (02607): PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION AND ABOLISHMENT OF THE SUPERVISORY BOARD AND PROPOSED AMENDMENTS TO THE RULES OF ... | ||
| SIHUAN PHARMACEUTICAL HOLDINGS GROUP | 0,153 | 0,00 % | Dividendenbekanntmachungen (26.09.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADF GROUP INC CA00089N1033 0,02 CAD 0,0123 EUR ALERUS FINANCIAL CORPORATION US01446U1034 0,21 USD 0,18 EUR ALICO INC US0162301040 0... ► Artikel lesen | |
| CHINA RESOURCES PHARMACEUTICAL | 0,540 | -3,57 % | Dividendenbekanntmachungen (11.09.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACADEMY SPORTS AND OUTDOORS INC US00402L1070 0,13 USD 0,1111 EUR ACTIA GROUP SA FR0000076655 - 0,12 EUR ADT INC US00090Q1031 0... ► Artikel lesen | |
| HANSOH PHARMACEUTICAL | 4,020 | +1,00 % | Dividendenbekanntmachungen (22.09.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AECON GROUP INC CA00762V1094 0,19 CAD 0,1173 EUR APT SATELLITE HOLDINGS LTD BMG0438M1064 0,025 HKD 0,0027 EUR ARROWMARK FINANCIAL... ► Artikel lesen | |
| CHINA SHINEWAY PHARMACEUTICAL GROUP | 1,050 | +5,00 % | SHINEWAY PHARM (02877): TURNOVER FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2025 | ||
| KALBE FARMA | 0,058 | -4,96 % | Kalbe Farma profit rises 10.63%, shares react positively: The shares of this Indeks52 constituent climb 3.25% ... | ||
| YICHANG HEC CHANGJIANG PHARMACEUTICAL | - | - | HEC CJ PHARM (01558): JOINT ANNOUNCEMENT UPDATE REGARDING CONDITIONAL PRIVATISATION OF YICHANG HEC CHANGJIANG PHARMACEUTICAL CO., LTD. BY SUNSHINE LAKE ... |
Das Unternehmen GLENMARK PHARMACEUTICALS LTD kann der Branche Pharma zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu GLENMARK PHARMACEUTICALS LTD finden Sie auf Wallstreet Online.